The Danish National Center for AI Innovations will soon get a new NVIDIA-powered AI supercomputer which is planned to be operational at the end of 2024.

Novo Nordisk Foundation (the parent company of Novo Nordisk, a Danish pharmaceutical corporation) has announced its intention to build a new artificial intelligence (AI) supercomputer for pharmaceutical research and development. Novo Nordisk has commissioned France’s Eviden a contract to build the computer in Copenhagen, Denmark.

The supercomputer, which will be housed in Denmark’s National Center for AI Innovation, is expected to be ready for pilot projects before the end of the year. Called “Gefion,” it will be available to researchers from Denmark’s public and private sectors and will be supported by two leading companies in the US and Europe.

The new supercomputer will consist of a large-scale NVIDIA DGX SuperPOD, powered by NVIDIA H100 Tensor Core GPUs and interconnected using NVIDIA Quantum-2 InfiniBand networking.

Funding is also being supplied by Denmark’s Export and Investment Fund of Denmark (EIFO). The company claims the new computer will be one of the world’s most powerful supercomputers, able to process vast amounts of data using AI.

Eviden, part of the Atos Group and a leading provider of advanced computing solutions in Europe, has been chosen to install, deliver, and configure the supercomputer at the Danish Centre for AI Innovation.

The center is expected to be up and running by the end of 2024 and will be available for pilot projects. The Novo Nordisk Foundation has pledged roughly DKK 600 million towards its initial costs, while EIFO has contributed DKK 100 million.